US FDA seeks more data for Novartis diabetes treatment (New Ratings)
LONDON, February 26 (newratings.com) The US Food & Drug Administration (FDA) has issued an approvable letter for Swiss drug giant Novartis AG s ( NOT.FSE ) Galvus drug for the treatment of type II diabetes, seeking additional data related to the drug.

Alpharma Reports Fourth Quarter 2006 EPS from Continuing Operations of $0.34 (PR Newswire via Yahoo! Finance)
Alpharma Inc. , a global specialty pharmaceutical company, announced fourth quarter 2006 diluted earnings per share from continuing operations of $0.34.